DIVA Laboratories Ltd (4153.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · Taiwan · ISIN TW0004153002

Price
30.90 TWD
Market cap
1.81 bn TWD
P/E (2025)
20.02
P/S (2025)
2.09
Dividend yield
6.47 %
Net margin
10.42 %
Return on equity (ROE)
8.80 %
Return on assets (ROA)
6.69 %

DIVA Laboratories Ltd financials

Fiscal year20242025
Revenue862.32 m TWD868.84 m TWD
Gross profit260.18 m TWD264.14 m TWD
Operating income102.57 m TWD109.36 m TWD
EBIT116.16 m TWD108.99 m TWD
Net income93.66 m TWD90.54 m TWD
Diluted EPS – continuing operations1.60 TWD1.54 TWD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About DIVA Laboratories Ltd

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.